-+ 0.00%
-+ 0.00%
-+ 0.00%

Susquehanna Upgrades RXO to Neutral, Lowers Price Target to $19

Benzinga·09/23/2026 17:45:32
Listen to the news
Susquehanna analyst Harrison Bauer upgrades RXO (NYSE:RXO) from Negative to Neutral and lowers the price target from $20 to $19.